InsiderClue
Insiders · Profile

Chu Yu-Waye

Chief Medical Officer at CytomX Therapeutics · Chief Medical Officer at FATE THERAPEUTICS. Filing since 16 Apr 2021. CIK 0001854586

CTMX CytomX Therapeutics, Inc. Chief Medical Officer · 2 trades FATE FATE THERAPEUTICS INC Chief Medical Officer · 6 trades
Company
Date
Role
Action
Shares
Amount
Of holding
CTMX CytomX Therapeutics, Inc.
17 Mar 2026
Chief Medical Officer
Sold at will
21,279
$136.68K
10.1%
CTMX CytomX Therapeutics, Inc.
18 Mar 2025
Chief Medical Officer
Sold at will
4,025
$2.41K
2.9%
FATE FATE THERAPEUTICS INC
18 Apr 2023
Chief Medical Officer
Sold on a plan
2,532
$16.65K
1.8%
FATE FATE THERAPEUTICS INC
10 Jan 2023
Chief Medical Officer
Sold, plan not stated
7,825
$41.00K
5.2%
FATE FATE THERAPEUTICS INC
19 Apr 2022
Chief Medical Officer
Sold, plan not stated
4,062
$143.67K
2.6%
FATE FATE THERAPEUTICS INC
11 Jan 2022
Senior VP Clinical Development
Sold, plan not stated
3,965
$192.34K
3.2%
FATE FATE THERAPEUTICS INC
10 Dec 2021
Senior VP Clinical Development
Sold, plan not stated
7,500
$385.95K
5.6%
FATE FATE THERAPEUTICS INC
16 Apr 2021
Senior VP Clinical Development
Sold, plan not stated
3,275
$272.81K
4.8%
8 decisions on file.